Dr. William F. Cothern, DO
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of North Texas Hsc, College of Osteopathic Med (1981)
- Years since graduation
- 45
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,116
Licensed in Texas since 1981, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1981Medical school: University of North Texas Hsc, College of Osteopathic Med
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
TX license F9330 (first issued 1981; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Oliver Street 5.01(a) Inc (168 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,116
- Services billed
- 7,856
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 2,610 | 417 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,544 | 910 |
| Destruction of precancer skin growth, 1 growth | 661 | 512 |
| Destruction of skin growth, 1-14 growths | 489 | 405 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 170 | 44 |
| New patient office or other outpatient visit, 30-44 minutes | 147 | 147 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 72 | 63 |
| Destruction of precancer skin growth, 15 or more growths | 67 | 57 |
| Established patient office or other outpatient visit, 30-39 minutes | 60 | 52 |
| Biopsy of related skin growth, first growth | 55 | 55 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Betamethasone Diprop Augmented (betamethasone/propylene glyc) | 239 |
| Clobetasol Propionate Other prescribers in Fort Worth, TX | 226 |
| Triamcinolone Acetonide Other prescribers in Fort Worth, TX | 188 |
| Doxycycline Hyclate Other prescribers in Fort Worth, TX | 181 |
| Ciclopirox Other prescribers in Fort Worth, TX | 89 |
| Terbinafine Hcl Other prescribers in Fort Worth, TX | 70 |
| Ketoconazole Other prescribers in Fort Worth, TX | 63 |
| Fluorouracil Other prescribers in Fort Worth, TX | 60 |
| Mupirocin Other prescribers in Fort Worth, TX | 55 |
| Metronidazole Other prescribers in Fort Worth, TX | 49 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 154 payments worth $3,588 in total to this clinician.
| AbbVie Inc. | $844 |
|---|---|
| Genzyme Corporation | $591 |
| Janssen Biotech, Inc. | $483 |
| Regeneron Healthcare Solutions, Inc. | $387 |
| UCB, Inc. | $224 |
| Novartis Pharmaceuticals Corporation | $207 |
| Sun Pharmaceutical Industries Inc. | $138 |
| Amgen Inc. | $97.52 |
| Food and Beverage | $3,582 |
|---|---|
| Education | $6.77 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Mar 6, 2025 | Education DUPIXENT · IMMUNOLOGY AND INFLAMMATION · in-kind | $6.77 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.